Huaping Dai

Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial.

Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial.

[Research progress of mesenchymal stem cell therapy in interstitial lung disease].

Clinical features and outcomes of 210 patients with idiopathic pulmonary fibrosis.

Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin.

Phosphatase and tensin homolog deleted on chromosome 10 contributes to phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis via multiple pathways.

Down-regulation of USP13 mediates phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis.

[Role and underlying mechanism of IGF-I/ERK signaling pathway in lung fibrosis].

[Idiopathic pulmonary fibrosis: cough and its treatment].

Pendrin, an anion exchanger on lung epithelial cells, could be a novel target for lipopolysaccharide-induced acute lung injury mice.

Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.

Targeting IL-17 attenuates hypoxia-induced pulmonary hypertension through downregulation of β-catenin.

Artificial Cough Maneuvers: A New Method of Secretion Clearance?

Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients.

Prevalence, risk factors, and management of asthma in China: a national cross-sectional study.

Single-cell RNA sequencing profiling of the effects of aging on alveolar stem cells.

Safety and diagnostic efficacy of cone beam computed tomography-guided transbronchial cryobiopsy for interstitial lung disease: a cohort study.

IL-25/IL-33/TSLP contributes to idiopathic pulmonary fibrosis: Do alveolar epithelial cells and (myo)fibroblasts matter?

Metformin ameliorates bleomycin-induced pulmonary fibrosis in mice by suppressing IGF-1.

SARS-CoV-2 and viral sepsis: observations and hypotheses.

Clinical characteristics of COVID-19 in patients with preexisting ILD: A retrospective study in a single center in Wuhan, China.

Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis.

Current therapies for patients with acute exacerbation of idiopathic pulmonary fibrosis.

Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study.

Direct medical costs of hospitalized patients with idiopathic pulmonary fibrosis in a tertiary hospital in China.

First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells.

Correction: Rapamycin increases CCN2 expression of lung fibroblasts via phosphoinositide 3-kinase.

Idiopathic Pulmonary Fibrosis Registry China study (PORTRAY): protocol for a prospective, multicentre registry study.

The effect of 1.9-mm versus 2.4-mm probes in transbronchial cryobiopsies for interstitial lung diseases: a prospective analysis.

Therapeutic Applications of Mesenchymal Stem Cells in Idiopathic Pulmonary Fibrosis.

A novel macrolide derivative ameliorates smoke-induced inflammation and emphysema by inhibiting NF-κB activation.

Association of fine particulate matter air pollution and its constituents with lung function: The China Pulmonary Health study.

Pirfenidone ameliorates silica-induced lung inflammation and fibrosis in mice by inhibiting the secretion of interleukin-17A.

Feasibility and Mechanism Analysis of Shenfu Injection in the Treatment of Idiopathic Pulmonary Fibrosis.

Coronavirus disease 2019-associated pulmonary fibrosis: clinical findings, pathogenesis, and potential treatment.

Global and regional burden of interstitial lung disease and pulmonary sarcoidosis from 1990 to 2019: results from the Global Burden of Disease study 2019.

Drug-induced pulmonary toxicity in breast cancer patients treated with systemic therapy: a systematic literature review.

Using contrast-enhanced CT and non-contrast-enhanced CT to predict EGFR mutation status in NSCLC patients-a radiomics nomogram analysis.

Long-Term Ozone Exposure and Small Airway Dysfunction: The China Pulmonary Health (CPH) Study.

A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019.

The Role of Diverse Immune Cells in Sarcoidosis.

Graft dysfunction and rejection of lung transplant, a review on diagnosis and management.

LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis.

Fatty Acid Metabolism and Idiopathic Pulmonary Fibrosis.

Associations of residential greenness with lung function and chronic obstructive pulmonary disease in China.

Safety and accuracy of transbronchial lung cryobiopsy in diagnosing desquamative interstitial pneumonia.

Single-Cell Transcriptomics Reveals Peripheral Immune Responses in Anti-Synthetase Syndrome-Associated Interstitial Lung Disease.

Telomere shortening impairs alveolar regeneration.

Dihydromyricetin Alleviates Pulmonary Fibrosis by Regulating Abnormal Fibroblasts Through the STAT3/p-STAT3/GLUT1 Signaling Pathway.

Development and Validation of a Screening Questionnaire of COPD from a Large Epidemiological Study in China.

Women in respiratory medicine: Perspectives from China Mainland and Hong Kong.

A Novel N-Arylpyridone Compound Alleviates the Inflammatory and Fibrotic Reaction of Silicosis by Inhibiting the ASK1-p38 Pathway and Regulating Macrophage Polarization.

Every road leads to Rome: therapeutic effect and mechanism of the extracellular vesicles of human embryonic stem cell-derived immune and matrix regulatory cells administered to mouse models of pulmonary fibrosis through different routes.

Construction and validation of prognostic nomograms for elderly patients with metastatic non-small cell lung cancer.

Chronic Obstructive Pulmonary Disease With Asthma-Like Features in the General Population in China.

Chest wall muscle mass depletion is related to certain pulmonary functions and diseases in patients with bronchiectasis.

Quantitative analysis of high-resolution computed tomography features of idiopathic pulmonary fibrosis: a structure-function correlation study.

Prevalence and burden of chronic cough in China: a national cross-sectional study.

Small airway dysfunction in Chinese patients with idiopathic pulmonary fibrosis.

Three-dimensional ultrashort echo time magnetic resonance imaging in assessment of idiopathic pulmonary fibrosis, in comparison with high-resolution computed tomography.

The associations of radiological features of high-resolution computed tomography with the outcomes of transbronchial cryobiopsy in interstitial lung diseases: A cohort study.

Extensive Pulmonary Cyst Formation in Erdheim-Chester Disease.

USP13 Deficiency Impairs Autophagy and Facilitates Age-related Lung Fibrosis.

A transcriptomics-based meta-analysis identifies a cross-tissue signature for sarcoidosis.

IL-17A promotes lung fibrosis through impairing mitochondrial homeostasis in type II alveolar epithelial cells.

Lung shrinking assessment on HRCT with elastic registration technique for monitoring idiopathic pulmonary fibrosis.

Blood monocyte counts as a prognostic biomarker and predictor in Chinese patients with idiopathic pulmonary fibrosis.

External validation of the GAP model in Chinese patients with idiopathic pulmonary fibrosis.

Characteristics of Diaphragmatic and Chest Wall Motion in People with Normal Pulmonary Function: A Study with Free-Breathing Dynamic MRI.

Malignancies in Patients with Interstitial Lung Diseases: A Single Center Observational Study.

The early and late intervention effects of collagen-binding FGF2 on elastase-induced lung injury.